top of page


  • Team Archbow

2021 Health System Specialty Pharmacy Trend Report

2021 Health System Specialty Pharmacy Trend Report

Perspectives from payers, manufacturers, and health systems

Trend Report available for download now.

Specialty medications create unique opportunities and challenges for healthcare providers in a variety of settings. While large national specialty pharmacies continue to dominate the market, health systems are rapidly building Specialty Pharmacy capabilities, creating an interesting alternative for manufacturers and payers. This is a trend we’ve been closely following for some time.

To aid our pharmaceutical market access clients in staying current on Health System Specialty Pharmacies (HSSPs) and their impact on the market, Archbow Consulting interviewed payers, pharmaceutical manufacturers, health system executives, and specialty pharmacy experts to provide a detailed view into the HSSP landscape and key stakeholder perspectives involved in shaping this dynamic market segment.

The results of our investigation provide actionable insights that create opportunities for greater collaboration between HSSPs, payers, and pharmaceutical manufacturers. Partnering more closely together presents an opportunity to enhance commercialization strategies, improve care coordination, and ultimately benefit the patients receiving vital treatments for complex and rare diseases.

The 2021 Health System Specialty Pharmacy Trend Report includes:

· A current landscape overview featuring HSSP market trends and insights

· Stakeholder perspectives from health systems, payers, and manufacturers

· Key takeaways for each stakeholder

The 2021 Health System Specialty Pharmacy Trend Report is available for free download now.

If you’re trying to determine how to maximize your relationship with HSSPs to increase access and improve outcomes for your patients, Archbow can help. Contact us today to put our team of pharmaceutical and biotech consulting experts to work for you.


Archbow Consulting helps pharma and biotech companies design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.

bottom of page